Delivery Order SPE2DB22D9244-SPE2DB25FZS96
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order from the Defense Logistics Agency valued at $16,249.95 for Stelara 90 mg/ml syringes. Awarded on September 17, 2025, with an ultimate completion date of October 8, 2025, this firm fixed-price delivery order carries no set-aside designation. The contract represents a direct procurement under DMS Pharmaceutical Group's existing Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $48,749.85 by the Defense Logistics Agency on September 12, 2025, for the supply of Stelara 90 mg/ml syringes. The contract contains no set-aside designation and is scheduled for completion by October 3, 2025, with performance taking place at the awardee's Park Ridge facility. This delivery order is issued under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency for Stelara 90 mg/mL syringes valued at $16,249.95. The award was issued on June 24, 2025, with an ultimate completion date of July 16, 2025, under a firm fixed-price delivery order contract with no set-aside designation. This delivery order represents a single procurement action under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $32,499.90 for Stelara 90 mg/mL syringes under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. The award, issued on August 29, 2025, with an ultimate completion date of September 22, 2025, represents a specific product delivery against the company's larger Indefinite Delivery Contract (IDC) with...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,249.95 on August 19, 2025, for the supply of Stelara 90 mg/ml syringes. The delivery order, which carries a firm fixed price and is not subject to any set-aside designation, is funded by the Defense Logistics Agency's Medical Supply Chain division and must be completed by September 10, 2025. This award represents a single delivery order...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) for the supply of Stelara 90 mg/mL syringes. The contract, awarded on July 23, 2025, carries an ultimate completion date of August 13, 2025, and represents a direct delivery order with no set-aside designation. This award falls under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $65K by the Defense Logistics Agency on September 5, 2025, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order is expected to be completed by September 26, 2025, and represents a continuation of the company's ongoing pharmaceutical supply relationship with the federal government. The award carries no set-aside...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency valued at $16,249.95 for Stelara 90 mg/ml syringes. The award, issued on September 23, 2025, with an ultimate completion date of October 15, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $40,179.29 by the Defense Logistics Agency on September 15, 2025. This delivery order, with an ultimate completion date of October 6, 2025, covers the supply of Stelara 90 mg/mL syringes to support Department of Defense healthcare operations. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency on September 12, 2025. This delivery order, without set-aside designation, calls for the supply of Stelara 90 mg/ml syringes to support Department of Defense healthcare requirements. The award is expected to be completed by October 3, 2025, with performance taking place at the...
- SPE2DB22D9244Indefinite Delivery Contract
- SPE2DB22D9244-SPE2DB25FZS96Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $32,308.74 by the Defense Logistics Agency on September 26, 2025, for the supply of Stelara 90 mg/ml syringes. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 20, 2025, and carries no set-aside designation. This award represents a direct distribution of a specialized pharmaceutical product to support the medical supply needs of Department of Defense healthcare facilities. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies. The company has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively for contracts supporting military health facilities nationwide. The current award for Stelara, a biologic immunosuppressant medication, exemplifies the specialized pharmaceutical products the contractor routinely delivers to government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.3k | 9/26/25 |